Thesis (Ph.D.) OGI School of Science & Engineering at OHSU, March 2008. / Includes bibliographical references (leaves 163 - 169).

Veterinary medicine in late-mediaeval England has thus far received little attention. This study therefore aims to partly fill this gap by providing an insight into English veterinary practices at this time. The introduction places the animals under discussion into context, from the noble war-horse to the lowly pig. Also discussed are the sources, with their intended audience and evidence for use. The first chapter concentrates on those who were responsible for treating animals when ill, examining the qualities sought in such people, and the source of their learning. In the second chapter the ailments suffered by mediaeval animals are discussed, together with the causes of illness and methods of diagnosis. The third, and final, chapter examines the treatment meted out to animals. Firstly the factors influencing this are explored, followed by surgical intervention, then therapeutic methods of treatment. The precautions taken when treating animals are looked at, as too is the efficacy of the remedies, whilst finally the preparation of medicines, the instruments used, and the materia medica employed are discussed. The aim of this study is not only to provide an insight into the state of veterinary medicine in late-mediaeval England, but also to adopt a broader and more comparative approach than has hitherto been undertaken. It therefore draws upon veterinary texts, hawking and hunting manuals, husbandry treatises, and recipe collections, in order to compare and contrast the ailments and treatment meted out to a variety of animals. Another important facet is to examine the reality of care, which is achieved through an examination of sources such as household and manorial accounts. By marrying the actuality of care with the theory and recommendations of treatises and recipe collections, our understanding of animal welfare is more greatly enhanced.

Made available in DSpace on 2016-01-26T18:55:28Z (GMT). No. of bitstreams: 1 Dissertacao.pdf: 196602 bytes, checksum: 4b736199198aa4dff1cbffd4f0155800 (MD5) Previous issue date: 2009-06-22 / The study aimed to evaluate through clinical examination and electrocardiogram in dogs, the effects of aminophylline used by inhalation and intravenous. Twelve dogs were divided into two groups: group AE (endovenous aminophylline) received 10 mg/kg of aminophylline intravenously and group AI (inhalatory aminophylline) received aminophylline to inhaled through the nebulizer at a dose of 10 mg/kg, diluted in 5 ml of solution of sodium chloride 0.9%. We observed five times and are considered MC (control phase), with evaluation just prior to administration of the drug and M30, M2, M6, M8 with assessments by the 30 minutes, 2 hours, 6 hours and 8 hours respectively. We evaluated the rectal temperature (TR), heart rate (FC), respiratory rate (f), systolic blood pressure (PAS) and electrocardiogram (ECG). The average FC, f and TR remained in normal range for that species. However, some animals, both of the AE and AI group showed a slight increase in FC. There was an increase of f in some animals in group AE in M30 and M6. There was an increase in TR in both groups, mainly in AE. The mean PAS was below the reference values in group AE in M6 and M30 and M8 in group AI. Sinus tachycardia was observed in both groups, earlier in group AE. Concluded that aminophylline administered by intravenous and inhalation routes causes clinical and electrocardiographic changes in dogs, including increased FC, TR and f, decrease in PAS and the occurrence of arrhythmia. / O estudo teve como objetivo avaliar através de exames clínico e eletrocardiográfico em cães, os efeitos da aminofilina utilizada por via inalatória e endovenosa. Doze cães foram distribuídos em dois grupos: o grupo AE (aminofilina endovenosa) recebeu 10 mg/kg de aminofilina via endovenosa e o grupo AI (aminofilina inalatória), recebeu a aminofilina via inalatória através do nebulizador, na dose de 10 mg/kg, diluída em 5ml de solução de cloreto de sódio 0,9%. Foram observados cinco momentos, sendo considerado MC (momento controle), com avaliação imediatamente antes da administração do fármaco e M30, M2, M6, M8 com avaliações realizadas 30 minutos, 2 horas, 6 horas e 8 horas após, respectivamente. Avaliou-se temperatura retal (TR), freqüência cardíaca (FC), freqüência respiratória (f), pressão arterial sistólica (PAS) e eletrocardiograma (ECG). A média da FC, f e TR se mantiveram na normalidade referida para a espécie. Entretanto, alguns animais, tanto do grupo AE quanto do grupo AI apresentaram aumento discreto da FC. Houve aumento da f em alguns animais do grupo AE, em M30 e M6. Observou-se aumento da TR nos dois grupos, principalmente no AE. A PAS média ficou abaixo dos valores de referência em M6 no grupo AE e em M30 e M8 no grupo AI. Taquicardia sinusal foi observada em ambos os grupos, mais precoce no grupo AE. Concluiu-se que a aminofilina administrada pelas vias endovenosa e inalatória provoca alterações clínicas e eletrocardiográficas em cães, incluindo aumento da FC, f e TR, diminuição da PAS e ocorrência de arritmia.

Made available in DSpace on 2016-07-18T17:53:06Z (GMT). No. of bitstreams: 1 Dissertacao.pdf: 196602 bytes, checksum: 4b736199198aa4dff1cbffd4f0155800 (MD5) Previous issue date: 2009-06-22 / The study aimed to evaluate through clinical examination and electrocardiogram in dogs, the effects of aminophylline used by inhalation and intravenous. Twelve dogs were divided into two groups: group AE (endovenous aminophylline) received 10 mg/kg of aminophylline intravenously and group AI (inhalatory aminophylline) received aminophylline to inhaled through the nebulizer at a dose of 10 mg/kg, diluted in 5 ml of solution of sodium chloride 0.9%. We observed five times and are considered MC (control phase), with evaluation just prior to administration of the drug and M30, M2, M6, M8 with assessments by the 30 minutes, 2 hours, 6 hours and 8 hours respectively. We evaluated the rectal temperature (TR), heart rate (FC), respiratory rate (f), systolic blood pressure (PAS) and electrocardiogram (ECG). The average FC, f and TR remained in normal range for that species. However, some animals, both of the AE and AI group showed a slight increase in FC. There was an increase of f in some animals in group AE in M30 and M6. There was an increase in TR in both groups, mainly in AE. The mean PAS was below the reference values in group AE in M6 and M30 and M8 in group AI. Sinus tachycardia was observed in both groups, earlier in group AE. Concluded that aminophylline administered by intravenous and inhalation routes causes clinical and electrocardiographic changes in dogs, including increased FC, TR and f, decrease in PAS and the occurrence of arrhythmia. / O estudo teve como objetivo avaliar através de exames clínico e eletrocardiográfico em cães, os efeitos da aminofilina utilizada por via inalatória e endovenosa. Doze cães foram distribuídos em dois grupos: o grupo AE (aminofilina endovenosa) recebeu 10 mg/kg de aminofilina via endovenosa e o grupo AI (aminofilina inalatória), recebeu a aminofilina via inalatória através do nebulizador, na dose de 10 mg/kg, diluída em 5ml de solução de cloreto de sódio 0,9%. Foram observados cinco momentos, sendo considerado MC (momento controle), com avaliação imediatamente antes da administração do fármaco e M30, M2, M6, M8 com avaliações realizadas 30 minutos, 2 horas, 6 horas e 8 horas após, respectivamente. Avaliou-se temperatura retal (TR), freqüência cardíaca (FC), freqüência respiratória (f), pressão arterial sistólica (PAS) e eletrocardiograma (ECG). A média da FC, f e TR se mantiveram na normalidade referida para a espécie. Entretanto, alguns animais, tanto do grupo AE quanto do grupo AI apresentaram aumento discreto da FC. Houve aumento da f em alguns animais do grupo AE, em M30 e M6. Observou-se aumento da TR nos dois grupos, principalmente no AE. A PAS média ficou abaixo dos valores de referência em M6 no grupo AE e em M30 e M8 no grupo AI. Taquicardia sinusal foi observada em ambos os grupos, mais precoce no grupo AE. Concluiu-se que a aminofilina administrada pelas vias endovenosa e inalatória provoca alterações clínicas e eletrocardiográficas em cães, incluindo aumento da FC, f e TR, diminuição da PAS e ocorrência de arritmia.